TAMOXIFEN FOR THE PRIMARY PREVENTION OF BREAST-CANCER - A REVIEW AND CRITIQUE OF THE CONCEPT AND TRIAL

被引：57
作者：
BUSH, TL
HELZLSOUER, KJ
机构：
[1] Department of Epidemiology, School of Public Health, The Johns Hopkins University, Baltimore, MD 21205
来源：
EPIDEMIOLOGIC REVIEWS | 1993年 / 15卷 / 01期
关键词：
D O I：
10.1093/oxfordjournals.epirev.a036110
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：233 / 243
页数：11
相关论文
共 43 条
[1]  
ASHFORD AR, 1988, CANCER, V61, P33, DOI 10.1002/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO
[2]  
2-I
[3]   LESSON OF THE WEEK - TAMOXIFEN RETINOPATHY - A RARE BUT SERIOUS COMPLICATION [J].
BENTLEY, CR ;
DAVIES, G ;
ACLIMANDOS, WA .
BRITISH MEDICAL JOURNAL, 1992, 304 (6825) :495-496
[4]  
BUSH TL, 1988, CLIN CHEM, V34, pB60
[5]   TAMOXIFEN-ASSOCIATED HEPATOCELLULAR DAMAGE AND AGRANULOCYTOSIS [J].
CHING, CK ;
SMITH, PG ;
LONG, RG .
LANCET, 1992, 339 (8798) :940-940
[6]  
DEGREGORIO MW, 1992, J NIH RES, V4, P84
[7]  
EBCTC Group, 1992, LANCET, V339, P1
[8]   BONE-MINERAL CONTENT OF WOMEN RECEIVING TAMOXIFEN FOR MASTALGIA [J].
FENTIMAN, IS ;
CALEFFI, M ;
RODIN, A ;
MURBY, B ;
FOGELMAN, I .
BRITISH JOURNAL OF CANCER, 1989, 60 (02) :262-264
[9]   A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J].
FISHER, B ;
COSTANTINO, J ;
REDMOND, C ;
POISSON, R ;
BOWMAN, D ;
COUTURE, J ;
DIMITROV, NV ;
WOLMARK, N ;
WICKERHAM, DL ;
FISHER, ER ;
MARGOLESE, R ;
ROBIDOUX, A ;
SHIBATA, H ;
TERZ, J ;
PATERSON, AHG ;
FELDMAN, MI ;
FARRAR, W ;
EVANS, J ;
LICKLEY, HL ;
KETNER, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :479-484
[10]  
FORNANDER T, 1989, LANCET, V1, P117
12345